For the quarter ending 2025-06-30, IKNA made $14,748K in revenue. -$2,767K in net income. Net profit margin of -18.76%.
| Income Statement | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Restructuring and other charges | 309 | 1,435 | 1,202 | 812 |
| Research and development | 4,025 | 3,715 | 8,019 | 6,818 |
| General and administrative | 4,416 | 5,644 | 6,301 | 4,777 |
| Total operating expenses | 8,750 | 10,794 | 15,522 | 12,407 |
| Loss from operations | -8,750 | -10,794 | -15,522 | -12,407 |
| Other income, net | 4,708 | 785 | 702 | 412 |
| Investment income | 1,290 | 1,418 | 1,867 | 1,771 |
| Total other income, net | 5,998 | 2,203 | 2,569 | 2,183 |
| Loss before income taxes | -2,752 | -8,591 | -12,953 | -10,224 |
| Income tax expense | 15 | 28 | 47 | 10 |
| Net loss | -2,767 | -8,619 | -13,000 | -10,234 |
| Unrealized gain on marketable securities | - | - | 721 | - |
| Total comprehensive loss | - | - | -12,279 | - |
| Earnings per share, basic | -0.06 | -0.18 | -0.27 | -0.21 |
| Earnings per share, diluted | -0.06 | -0.18 | -0.27 | -0.21 |
| Weighted average number of shares outstanding, basic | 48,258,111 | 48,258,111 | 0 | 48,258,111 |
| Weighted average number of shares outstanding, diluted | 48,258,111 | 48,258,111 | 0 | 48,258,111 |
Ikena Oncology, Inc. (IKNA)
Ikena Oncology, Inc. (IKNA)